Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.3, was added to the study record history, and the previous revision, Revision: v3.6.2, was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-04T13:19:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision version was updated to v3.6.2, replacing the previous v3.6.0, indicating a backend/UI update to the study history view.
    Difference
    0.1%
    Check dated 2026-06-27T06:23:56.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Adds a recruitment-status note 'No longer looking for participants' to the study history, indicating enrollment is no longer active. The history also introduces the revision tag v3.6.0 and removes the older revision tag v3.5.5, updating the record's version history.
    Difference
    0.3%
    Check dated 2026-06-13T00:39:57.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The history now includes a new revision entry (v3.5.5) and removes the prior revision (v3.5.4), reflecting an update to the page’s version history.
    Difference
    0.1%
    Check dated 2026-06-05T22:08:50.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new revision label, v3.5.4, has been added to the page, replacing the previous v3.5.3. This change updates the page's revision history metadata.
    Difference
    0.1%
    Check dated 2026-05-15T14:14:28.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The change reflects an update to the ClinicalTrials.gov record history page/versioning and revision label rather than substantive changes to the study information itself.
    Difference
    0.5%
    Check dated 2026-04-24T06:10:59.000Z thumbnail image

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.